These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11072174)

  • 1. Models for estimation of the (10)B concentration after BPA-fructose complex infusion in patients during epithermal neutron irradiation in BNCT.
    Ryynänen PM; Kortesniemi M; Coderre JA; Diaz AZ; Hiismäki P; Savolainen SE
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1145-54. PubMed ID: 11072174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
    Chadha M; Capala J; Coderre JA; Elowitz EH; Iwai J; Joel DD; Liu HB; Wielopolski L; Chanana AD
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):829-34. PubMed ID: 9531367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary treatment planning and dosimetry for a clinical trial of neutron capture therapy using a fission converter epithermal neutron beam.
    Kiger WS; Lu XQ; Harling OK; Riley KJ; Binns PJ; Kaplan J; Patel H; Zamenhof RG; Shibata Y; Kaplan ID; Busse PM; Palmer MR
    Appl Radiat Isot; 2004 Nov; 61(5):1075-81. PubMed ID: 15308195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
    Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
    Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced blood boron concentration estimation for BPA-F mediated BNCT.
    Kortesniemi M; Seppälä T; Auterinen I; Savolainen S
    Appl Radiat Isot; 2004 Nov; 61(5):823-7. PubMed ID: 15308151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term infusions of p-boronophenylalanine for boron neutron capture therapy: evaluation using rat brain tumor and spinal cord models.
    Morris GM; Micca PL; Nawrocky MM; Weissfloch LE; Coderre JA
    Radiat Res; 2002 Dec; 158(6):743-52. PubMed ID: 12452777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex.
    Coderre JA; Button TM; Micca PL; Fisher CD; Nawrocky MM; Liu HB
    Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):643-52. PubMed ID: 7928496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodistribution studies of boronophenylalanine-fructose in melanoma and brain tumor patients in Argentina.
    Liberman SJ; Dagrosa A; Jiménez Rebagliati RA; Bonomi MR; Roth BM; Turjanski L; Castiglia SI; González SJ; Menéndez PR; Cabrini R; Roberti MJ; Batistoni DA
    Appl Radiat Isot; 2004 Nov; 61(5):1095-100. PubMed ID: 15308198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boron neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons: trial design and early clinical results.
    Coderre JA; Elowitz EH; Chadha M; Bergland R; Capala J; Joel DD; Liu HB; Slatkin DN; Chanana AD
    J Neurooncol; 1997 May; 33(1-2):141-52. PubMed ID: 9151231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
    Barth RF; Yang W; Rotaru JH; Moeschberger ML; Boesel CP; Soloway AH; Joel DD; Nawrocky MM; Ono K; Goodman JH
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):209-18. PubMed ID: 10758326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pharmacokinetic model for the concentration of 10B in blood after boronophenylalanine-fructose administration in humans.
    Kiger WS; Palmer MR; Riley KJ; Zamenhof RG; Busse PM
    Radiat Res; 2001 Apr; 155(4):611-8. PubMed ID: 11260663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dose and infusion time on the delivery of p-boronophenylalanine for neutron capture therapy.
    Joel DD; Coderre JA; Micca PL; Nawrocky MM
    J Neurooncol; 1999 Feb; 41(3):213-21. PubMed ID: 10359141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved survival after boron neutron capture therapy of brain tumors by Cereport-mediated blood-brain barrier modulation to enhance delivery of boronophenylalanine.
    Yang W; Barth RF; Bartus RT; Rotaru JH; Moeschberger ML; Ferketich AK; Nawrocky MM; Coderre JA; Goodman JH
    Neurosurgery; 2000 Jul; 47(1):189-97; discussion 197-8. PubMed ID: 10917362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boron neutron capture therapy of brain tumors: clinical trials at the finnish facility using boronophenylalanine.
    Joensuu H; Kankaanranta L; Seppälä T; Auterinen I; Kallio M; Kulvik M; Laakso J; Vähätalo J; Kortesniemi M; Kotiluoto P; Serén T; Karila J; Brander A; Järviluoma E; Ryynänen P; Paetau A; Ruokonen I; Minn H; Tenhunen M; Jääskeläinen J; Färkkilä M; Savolainen S
    J Neurooncol; 2003; 62(1-2):123-34. PubMed ID: 12749708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning.
    Kabalka GW; Smith GT; Dyke JP; Reid WS; Longford CP; Roberts TG; Reddy NK; Buonocore E; Hübner KF
    J Nucl Med; 1997 Nov; 38(11):1762-7. PubMed ID: 9374349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study.
    Bergenheim AT; Capala J; Roslin M; Henriksson R
    J Neurooncol; 2005 Feb; 71(3):287-93. PubMed ID: 15735919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boron neutron capture therapy (BNCT): implications of neutron beam and boron compound characteristics.
    Wheeler FJ; Nigg DW; Capala J; Watkins PR; Vroegindeweij C; Auterinen I; Seppälä T; Bleuel D
    Med Phys; 1999 Jul; 26(7):1237-44. PubMed ID: 10435523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-boronophenylalanine-mediated boron neutron capture therapy for malignant glioma progressing after external beam radiation therapy: a Phase I study.
    Kankaanranta L; Seppälä T; Koivunoro H; Välimäki P; Beule A; Collan J; Kortesniemi M; Uusi-Simola J; Kotiluoto P; Auterinen I; Serèn T; Paetau A; Saarilahti K; Savolainen S; Joensuu H
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):369-76. PubMed ID: 21236605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton nuclear magnetic resonance measurement of p-boronophenylalanine (BPA): a therapeutic agent for boron neutron capture therapy.
    Zuo CS; Prasad PV; Busse P; Tang L; Zamenhof RG
    Med Phys; 1999 Jul; 26(7):1230-6. PubMed ID: 10435522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced survival of glioma bearing rats following boron neutron capture therapy with blood-brain barrier disruption and intracarotid injection of boronophenylalanine.
    Yang W; Barth RF; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH
    J Neurooncol; 1997 May; 33(1-2):59-70. PubMed ID: 9151224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.